01:14 , Aug 17, 2006 |  BC Extra  |  Financial News

TolerRx raises $35.6 million

TolerRx ( Cambridge , Mass.) raised $35.6 million in a series E round led by new investor FrontPoint Partners. Other new investors Mesirow Financial; Swiss Re; QVT Fund; IBT Management Corp.; Brookstone Capital; and the...
08:00 , Oct 31, 2005 |  BioCentury  |  Finance

Ebb & Flow

Cerimon's $70 million series A round probably turned some heads last week, as the company's lone products are topical formulations of diclofenac, an NSAID that's rather long of tooth. However, the company's directors and investors...